Xavier Matias-Guiu Guia
Grado: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grupos
Publicaciones
-
MATIAS-GUIU GUIA, XAVIER
Endometrial Cancer Histopathology Reporting Guide
Endometrial Cancer Histopathology Reporting Guide -. .
-
Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
GYNECOLOGIC ONCOLOGY 159 721-731. .
-
Miller RE; Leary A; Scott CL; Serra V; Lord CJ; Bowtell D; Chang DK; Garsed DW; Jonkers J; Ledermann JA; Nik-Zainal S; Ray-Coquard I; Shah SP; Matias-Guiu X; Swisher EM; Yates LR
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.
ANNALS OF ONCOLOGY 31 1606-1622. .
-
Mellid S; Coloma J; Calsina B; Monteagudo M; Roldán-Romero JM; Santos M; Leandro-García LJ; Lanillos J; Martínez-Montes ÁM; Rodríguez-Antona C; Montero-Conde C; Martínez-López J; Ayala R; Matias-Guiu X; Robledo M; Cascón A
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.
Cancers 12 1-12. .
-
Rodriguez-Hernandez I; Maiques O; Kohlhammer L; Cantelli G; Perdrix-Rosell A; Monger J; Fanshawe B; Bridgeman VL; Karagiannis SN; Penin RM; Marcolval J; Marti RM; Matias-Guiu X; Fruhwirth GO; Orgaz JL; Malanchi I; Sanz-Moreno V
WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.
Nature Communications 11 5315-5315. .
-
Cuatrecasas M; Gorostiaga I; Riera C; Saperas E; Llort G; Costa I; Matias-Guiu X; Carrato C; Navarro M; Pineda M; Dueñas N; Brunet J; Marco V; Trias I; Busteros JI; Mateu G; Balaguer F; Fernández-Figueras MT; Esteller M; Musulén E
Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia.
Cancers 12 1-20. .
-
Megino-Luque C; Moiola CP; Molins-Escuder C; López-Gil C; Gil-Moreno A; Matias-Guiu X; Colas E; Eritja N
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer.
Cancers 12 1-26. .
-
Da Cruz Paula A; da Silva, EM; Segura, SE; Pareja, F; Bi, R; Selenica, P; Kim, SH; Ferrando, L; Vahdatinia, M; Soslow, RA; Vidal, A; Gatius, S; Przybycin, CG; Abu-Rustum, NR; Matias-Guiu, X; Rubin, BP; Reis, JS; DeLair, DF; Weigelt, B
Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
Modern Pathology 33 1606-1617. .
-
Damaso, E; Gonzalez-Acosta, M; Vargas-Parra, G; Navarro, M; Balmaña J; Ramon Y Cajal T; Tuset, N; Thompson, BA; Marin, F; Fernandez, A; Gomez, C; Velasco À; Solanes, A; Iglesias, S; Urgel, G; Lopez, C; del Valle, J; Campos, O; Santacana, M; Matias-Guiu, X; Lazaro, C; Valle, L; Brunet, J; Pineda, M; Capella, G
Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals.
Cancers 12 1-32. .
-
Mayo-de-las-Casas, C; Velasco, A; Sanchez, D; Martínez-Bueno A; Garzón-Ibáñez M; Gatius, S; Ruiz-Mir?, M; Gonzalez-Tallada, X; Llordella, I; Tresserra, F; Rodríguez S; Aldeguer, E; Roman-Canal, B; Bertran-Alamillo, J; García-Peláez B; Rosell, R; Molina-Vila, MA; Matias-Guiu, X
Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: a proof-of-concept study.
INTERNATIONAL JOURNAL OF CANCER 147 277-284. .
-
Matias-Guiu, Xavier
Nuevos tiempos, nuevas prioridades.
Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 53 137-137. .
-
Alonso-Alconada, L; de la Fuente, A; Santacana, M; Ferreiros, A; Lopez-Lopez, R; Matias-Guiu, X; Abal, M
Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer.
DISEASE MODELS & MECHANISMS 13 -. .
Proyectos
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
- Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment